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Abstract 
Background: Settings affect estimation of multimorbidity prevalence. Multimorbidity prevalence was reported to be 
substantially higher among family practice‑based patients than in the general population, but prevalence estimates 
were obtained with different methods and at different time periods. The aim of the present study was to compare 
estimates of the prevalence of multimorbidity in the general population and in primary care clinical practices, both 
measured simultaneously and with the same methods.
Methods: Cross‑sectional analysis of results from the Program of Research on the Evolution of a Cohort Investigat‑
ing Health System Effects (PRECISE) in Quebec, Canada. Subjects aged between 25 and 75 years. A randomly‑selected 
cohort in the general population recruited by telephone, and patients recruited in the waiting room of 12 primary 
care clinics. Prevalence of multimorbidity was estimated using three operational definitions of multimorbidity: (a) two 
or more chronic conditions (MM 2+); (b) three or more chronic conditions (MM 3+); and (c) disease burden morbidity 
assessment score of 10 or higher (DBMA 10+).
Results: Prevalence in the general population ranged from 59.4 % (with MM2+) to 16.9 %, (with DBMA10+). In 
primary care practices, prevalence estimates ranged from 69.5 to 29.5 %. Prevalence estimates of multimorbidity were 
about 10 % higher in primary care clinical practices than in the sample from the general population. The difference 
was not importantly affected by the use of different operational definitions of multimorbidity. Also, there was a higher 
burden of disease among patients attending primary care clinics.
Conclusions: The study suggests that the problem of multimorbidity in the two settings is different both quanti‑
tatively (a higher proportion of patients with multimorbidity in primary care clinical practices), and qualitatively (a 
higher disease burden of patients attending primary care clinics). For decision‑makers interested in resource alloca‑
tion, prevalence estimates in samples from primary care practices are more informative than estimates in the general 
population, but burden of disease should also be considered as it results in more complexity in primary care clinical 
practices.
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Background
Point prevalence is the proportion of a population 
affected by a health condition at a given moment in time 
and it provides a snapshot of the burden of disease in 
that population. Multimorbidity is the co-occurrence of 
chronic illnesses in the same person and its prevalence 
provides a picture of the complexity of the burden of 
chronic illness. It has been reported that settings (general 
population, primary care practices) affect estimation of 
prevalence of multimorbidity [1–3]. In a previous study 
we suggested that age-standardized estimates of multi-
morbidity prevalence were substantially higher in a fam-
ily practice-based sample of patients than in the general 
population [2]. However, the prevalence estimates in the 
two populations were obtained with different methods of 
collecting data, and conducted at different time periods 
[2]. Consequently, it was not possible to conclude defini-
tively the extent to which prevalence estimates differ in 
these two study populations. We also suggested that esti-
mates are not only higher in primary practice samples 
when multimorbidity was defined as two-plus chronic 
diseases, but also that the difference in prevalence with 
the general population became more marked when mul-
timorbidity was defined as three-plus chronic diseases 
[2]. Compared to two or more diagnoses, the latter defi-
nition results in a lower prevalence of multimorbidity 
and likely better identifies patients with higher needs, 
and thus may be more meaningful for clinicians than a 
count of two or more, which is less discriminating. How-
ever, additional research is needed about the effects of 
using different definitions of multimorbidity [4].
The principal aim of the present study was to com-
pare estimates of the prevalence of multimorbidity in 
the general population and in primary care clinical prac-
tices, both measured simultaneously, in the same region 
and with the same methods. The secondary objective of 
the study aimed at exploring the effect of using different 
operational definitions of multimorbidity on the differ-




The present cross-sectional study is a secondary analysis 
conducted among parallel samples of the general popu-
lation and primary care patients recruited for a larger 
cohort study (the Program of Research on the Evolution 
of a Cohort Investigating Health System Effects, PRE-
CISE) [5] within the geographic boundaries of four local 
healthcare networks in Quebec, Canada. These networks 
are located in metropolitan, urban, rural and remote 
areas. The study was approved by the scientific and ethics 
committees of the Centre de santé et de services sociaux 
de Chicoutimi, as well as the Research Ethics Committee 
of Hôpital Charles Lemoyne, Quebec.
Participants
All participants had to be aged between 25 and 75 years, 
able to respond to written and oral questions in English 
or French and reside in one of the four networks identi-
fied. The general population sample was selected by ran-
dom digit dialing from March to April 2010 within the 
administrative boundaries of the four networks. Once 
contact was made, staff selected the eligible adult in the 
household with the most recent birthday to ensure ran-
dom selection.
The primary care patient sample was also recruited 
from March to April 2010 by research assistants recruit-
ing patients in the waiting room of 12 primary care clinics 
located within the networks identified. In each of the four 
networks, we purposefully selected three sentinel clin-
ics typical of the dominant forms of primary healthcare 
organizations: private medical clinics, community health 
clinics, and Family Medicine Groups. To be included in 
the study, participants had to be a regular patient of the 
clinic and be consulting for themselves in addition to be 
aged between 25 and 75 years, able to respond to written 
and oral questions in English or French and reside in one 
of the four networks identified.
Data collection
At recruitment, participants reported on socio-demo-
graphic information (age, gender, education level, per-
ceived financial situation, house ownership, presence 
or absence of medical insurance, the possession of a 
retirement plan). Based on these data, we produced a 
data-driven classification of socio-economic status and 
classified patients into four socio-economic clusters: elite 
group, middle-high, middle-low, and low. Definitional 
criteria for the four socio-economic clusters have been 
previously described [6]. After recruitment, a self-admin-
istered questionnaire was mailed to the subjects included 
in the general population sample. The same question-
naire was given to the patients recruited in primary care. 
Among other instruments, the questionnaire included 
the disease burden morbidity assessment (DBMA) [7, 
8]. The instrument elicits whether the patient has been 
diagnosed by a health professional with or is taking any 
medications from a list of 21 conditions [7, 8]. For each 
condition present, the patient assesses the degree to 
which the condition limits his/her daily activities on a 
five-point descriptive scale from 1 = “not at all” to 5 = “a 
lot”; absence of the conditions is scored zero. The total 
DBMA score is the sum of the limitation from all condi-
tions. We also made a simple count of chronic conditions 
present in each subject from the list of 21 conditions.
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We used three operational definitions for multimorbid-
ity: (1) the presence of two or more chronic conditions 
(MM 2+); (2) the presence of three or more chronic 
conditions (MM 3+); (3) DBMA score of 10 or higher 
(DBMA 10+). The definition of multimorbidity based on 
DBMA 10+ arises from the clinical experience that it is 
a threshold of the DBMA score that may correspond to 
patients with several chronic diseases that individually 
have a minimal impact on the daily living of a patient, 
or the presence of at least two chronic diseases with an 
important impact on patient’s daily living. This definition 
of multimorbidity was proposed in the protocol of the 
project PRECISE [5], and used in that study.
Data analysis
The sociodemographic characteristics as well as number 
of diseases and DBMA scores of the samples were ana-
lyzed with descriptive statistics. To compare the extent to 
which the two samples differed, the Student’s t test was 
used to measure possible differences of continuous vari-
ables, and the Chi squared test was used to test possible 
differences between categorical variables. Subsequently, 
we calculated age-standardized prevalence by direct 
standardization using the general population of Quebec 
as a Ref. [9]. To determine the extent to which the esti-
mates where statistically significantly in the samples, we 
calculated Fisher’s 95  % confidence intervals (95  % CI) 
looking for overlap. No overlap of 95  % CI was consid-
ered a statistical significant difference. All the analyses 
were done using SPSS version 20. The alpha significance 
level was set at 0.05.
Results
In the general population, a total of 2458 subjects were 
contacted. Among them, 2409 subjects were eligible, and 
1718 (70 % of those initially contacted) returned the com-
pleted questionnaires. In the primary care clinics, 1058 
subjects were contacted, and 1029 of them were eligible. 
Questionnaires were returned by 789 subjects, that is, 
75 % of the subjects initially contacted.
Characteristics of participants in both samples are 
shown in Table 1. Age and sex distribution were signifi-
cantly different between the samples from the two set-
tings, being the sample from primary care clinics older 
and with a greater proportion of female subjects. The 
burden of disease, measured either by the number of 
chronic conditions or by the DBMA score was signifi-
cantly higher in the whole sample from primary care clin-
ics than in the one from the general population.
Although sex distribution was different between the 
samples, prevalence estimations by sex within each sam-
ple were not significantly different for any of the three 
operational definitions of multimorbidity (see Appendix). 
Therefore, prevalence difference between the two cohorts 
was analyzed by grouping males and females. Table  2 
shows prevalence estimates in the general population and 
primary care practices according to the different opera-
tional definitions of multimorbidity. Prevalence in the 
general population ranged from 59.4  %—for the opera-
tional definition that included subjects with less disease 
burden (MM2+)—to 16.9 %, for the definition selecting 
sicker subjects (DBMA10+). In primary care practices, 
prevalence estimates ranged from 69.5 to 29.5 %. The dif-
ference between the two settings across all definitions 
was about 10 % higher in primary care. To further analyze 
the observed differences, we estimated age-standardized 
prevalence to compare the two cohorts. Table 3 shows the 
age-standardized prevalence in the two cohorts accord-
ing to the different operational definitions of multimor-
bidity. The age-standardized prevalence estimates were 
somewhat lower than those non-standardized (mean dif-
ference of 1.4 %), but there was still a difference between 
the two samples which varied from 8.1 to 9.3 % across the 
different operational definitions of multimorbidity. In all 
analyses, there was no overlap of 95 % confidence inter-
vals of prevalence estimates in the two samples with any 
of the definitions of multimorbidity.
Discussion
Prevalence estimates of multimorbidity are important for 
reporting about the health status of a given population. 
Measurements of multimorbidity in different settings 
are expected not only to generate different estimates of 
prevalence, but also to provide different information [1–
3]. Estimates of the prevalence of multimorbidity based 
on measures in a sample of the general population pro-
vide information about the magnitude of the burden of 
chronic illness in a given location. On the other hand, 
measuring the prevalence of multimorbidity in a sample 
of patients attending clinical consultation in primary care 
practices provides insight into the physician’s daily work. 
Looking at the results in primary care practices, we may 
say that almost half of patients attending primary care 
clinics had multimorbidity, as defined by MM3+, and 
almost one patient out of four had high disease burden, 
as defined by DBMA 10+. This way of looking at the 
situation probably provides a better idea of the workload 
faced by physicians in primary care practices.
As we mentioned before, previous studies comparing 
prevalence of multimorbidity in the general population 
and the population of patients attending clinical consul-
tation in primary care had different methods of collect-
ing data that could have influenced the results [1–3]. The 
present study used the same methods of data collection 
in both populations and showed that prevalence esti-
mates of multimorbidity measured in a sample of patients 
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from the waiting room of primary care clinics were about 
10  % higher than estimates in a sample from the gen-
eral population. The difference between the two samples 
was similar across the three operational definitions of 
multimorbidity used to measure the prevalence. Two 
important conclusions can be drawn from this. First, the 
Table 1 Characteristics of participants
DBMA disease burden morbidity assessment; MM 2+ subjects with two or more chronic conditions; MM 3+ subjects with three or more chronic conditions; DBMA 10+ 
subjects with DBMA score of 10 or higher
Mean (SD) p
General population  
n = 1718
Primary care  
n = 789
Age, year 51.3 (12.5) 53.0 (12.9) 0.002
Number of chronic conditions 2.6 (2.5) 3.3 (2.8) <0.001
 Chronic conditions in subgroup MM 2+ 4.1 (2.1) 4.6 (2.4) <0.001
 Chronic conditions in subgroup MM 3+ 4.9 (2.0) 5.3 (2.3) 0.002
DBMA score 4.9 (6.0) 6.9 (7.7) <0.001
 DBMA in subgroup DBMA 10+ 15.6 (6.3) 17.2 (7.8) 0.017
N (%) p
Males 699 (40.7) 253 (32.1) <0.001
Education level
 Incomplete secondary school or lower 378 (22.0) 153 (19.4) 0.097
 Completed secondary school 521 (30.3) 263 (33.3)
 College 393 (22.9) 189 (24.0)
 University 418 (24.3) 164 (20.8)
 Missing data 8 (0.5) 20 (2.5)
Socio‑economic classes
 Elite group 338 (19.7) 155 (19.6) 0.317
 Middle‑high 737 (42.9) 335 (42.5)
 Middle‑low 345 (20.1) 138 (17.5)
 Low 230 (13.4) 122 (15.5)
 Missing data 68 (4.0) 39 (4.9)
Table 2 Prevalence in the general population and primary care practices according to different operational definitions 
of multimorbidity
MM 2+ subjects with two or more chronic conditions; MM 3+ subjects with three or more chronic conditions; DBMA 10+ subjects with DBMA score of 10 or higher
General population prevalence  
(95 % confidence interval)
Primary care prevalence  
(95 % confidence interval)
Difference %
MM 2+ 59.4 (56.8–61.8) 69.5 (66.0–72.6) 10.1
MM 3+ 43.7 (41.2–46.2) 54.4 (50.6–57.8) 10.7
DBMA 10+ 16.9 (15.2–18.8) 26.5 (23.2–29.4) 9.6
Table 3 Age-standardized prevalence in the general population and primary care practices according to different opera-
tional definitions of multimorbidity
MM 2+ subjects with two or more chronic conditions; MM 3+ subjects with three or more chronic conditions; DBMA 10+ subjects with DBMA score of 10 or higher
General population prevalence  
(95 % confidence interval)
Primary care prevalence  
(95 % confidence interval)
Difference %
MM 2+ 53.68 (53.64–53.72) 62.94 (62.90–62.97) 9.3
MM 3+ 37.75 (37.71–37.79) 45.85 (45.81–45.89) 8.1
DBMA 10+ 14.19 (14.16–14.22) 22.94 (22.90–22.97) 8.8
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difference is smaller than previously reported (roughly, 
35 %) [2] but could still be explained by the oversampling 
of frequent attendees with higher needs in primary care 
practices which is an important reality. Secondly, at vari-
ance with what was previously reported, the difference 
remains stable across definitions of multimorbidity when 
the same method is used in both cohorts.
A closer look at the data showed that the increased prev-
alence in the primary care practices was only one aspect of 
the difference in multimorbidity between the two samples. 
Within each sample, choosing operational definitions of 
multimorbidity that include subjects with increased dis-
ease burden (MM2 + < MM3 + < DBMA 10+) have the 
effect of decreasing prevalence estimates. However, in the 
sample from primary care clinics we observed not only 
higher prevalence estimates of multimorbidity (Table 2) but 
also higher burden of disease (Table 1) than in the sample 
from the general population for each operational definition. 
This means that the workload generated by multimorbid-
ity in primary care practices, as compared with the general 
population, includes two elements: (1) a higher proportion 
of patients with multimorbidity; and (2) a higher burden 
of disease of patients attending primary care clinics (not 
measured by prevalence estimates). Of particular interest is 
the subgroup of patients with DBMA10+ in each sample. 
The mean DBMA score for patients in the DBMA10+ sub-
group was significantly higher in those attending primary 
care clinics (Table  1). The age-standardized prevalence 
was almost double in the same group as compared with 
the sample from the general population (Table 3). It is very 
likely that we may find among this group the most complex 
patients with an important level of health care utilization 
and higher costs for the health care system [10, 11].
Our study has limitations. Regarding the measurement 
of multimorbidity, we considered 21 frequent chronic con-
ditions, and this has an influence on prevalence estimates 
of multimorbidity. We have previously reported that a 
longer list of conditions would result in higher prevalence 
estimates [2]. Also, we had to rely on the self-reported 
presence of chronic conditions to measure multimorbidity 
and, hence, either over-reporting or under-reporting may 
have occurred [12, 13]. Finally, caution should be taken 
when the results of this study are extrapolated to different 
contexts or to other populations different from the Cana-
dian population where the study was conducted.
Conclusions
We found that there is a difference of about 10  % 
in prevalence estimates of multimorbidity between 
samples from the general population and primary 
care clinical practices which is not affected by the 
use of different operational definitions of multi-
morbidity. The study suggests that the problem of 
multimorbidity in the two settings is different both 
quantitatively (a higher proportion of patients with 
multimorbidity in primary care clinical practices), 
and qualitatively (a higher disease burden of patients 
attending primary care clinics). For decision-makers 
interested in resource allocation, prevalence esti-
mates in samples from primary care practices are 
more informative than estimates in the general pop-
ulation but burden of disease should also be consid-
ered as it results in more complexity in primary care 
clinical practices.
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